• 2'3'-cGAMP: From Mechanism to STING Translation

  2026-08-14

  A translational framework for using 2'3'-cGAMP (sodium salt) to connect cGAS-STING mechanism, delivery strategy, assay validation, and immunotherapy research. The discussion uses recent lipid nanoparticle evidence in pancreatic cancer to show why ligand potency and intracellular access must be evaluated together.

• Ciclesonide in Reliable Cell Assays

  2026-08-14

  Learn how Ciclesonide (SKU B3477) can be integrated into cell viability, proliferation, and cytotoxicity workflows with careful control of prodrug activation, solvent exposure, storage, and interpretation. The article connects product-specific quantitative data with practical assay decisions and distinguishes glucocorticoid research from emerging ERAD-based degradation technologies.

• EZ Cap™ Firefly Luciferase mRNA: Assay Design

  2026-08-13

  EZ Cap™ Firefly Luciferase mRNA can function as more than a bioluminescent endpoint: it is a controlled probe for separating RNA delivery, cytosolic translation, and biological context. This article translates recent lipid nanoparticle evidence into practical assay-design decisions for reproducible reporter studies.

• Z-DEVD-FMK: From Apoptosis Tool to Translational Probe

  2026-08-13

  Z-DEVD-FMK is more than a standard caspase-3 inhibitor: its irreversible, cell-permeable activity also intersects with caspase-6 signaling and calpain-mediated proteolysis. This thought-leadership analysis translates those properties into stronger apoptosis assays, neuroprotection studies, and antiviral research strategies while defining the limits of pharmacological interpretation.

• Rucaparib (AG-014699) for DNA Damage Workflows

  2026-08-12

  Rucaparib (AG-014699) enables controlled studies of PARP1 inhibition, persistent DNA breaks, and radiation response in repair-deficient cancer models. This workflow pairs practical radiosensitization assays with the emerging RNA Pol II degradation-dependent apoptotic response, while separating established mechanisms from testable hypotheses.

• AMG 487: Reading CXCR3 Signaling in Context

  2026-08-12

  AMG 487 is a potent CXCR3 antagonist for dissecting chemokine-driven migration, calcium signaling, and macrophage-state transitions. This article explains why inflammatory context and LAMP1 status are essential for interpreting CXCR3 inhibition experiments.

• 5-EdU for Cell Proliferation and Tumor Research

  2026-08-11

  Learn how to use 5-EdU as a rapid, antibody-free readout of DNA synthesis, from cultured pancreatic cancer cells to tissue regeneration models. This workflow combines practical pulse-labeling guidance with troubleshooting strategies and assay choices informed by recent CDK4/6–BET inhibitor research.

• (R)-MG132: Making Proteasome Mechanisms Credible

  2026-08-10

  A thought-leadership guide to using (R)-MG132 as a stereochemical negative control when testing proteasome-dependent protein stability, cancer metabolism, and HNRNPU–PHGDH mechanisms.

• Antiepileptic Inhibition of Human Aromatase (CYP19)

  2026-08-09

  Jacobsen, Halling-Sørensen, and Birkved evaluated twelve antiepileptic drugs in a recombinant human aromatase assay and identified lamotrigine among seven compounds capable of reducing CYP19 activity. The study provides a useful biochemical screen for investigating endocrine off-target effects, while its high test concentrations and microsomal design require caution when translating results to patients.

• YC-1 Workflows for Hypoxia and Cancer Research

  2026-08-08

  YC-1 combines soluble guanylyl cyclase activation with suppression of hypoxia-inducible signaling, making it useful for linking pathway modulation to tumor-cell and angiogenesis phenotypes. This practical guide covers dosing, hypoxia workflows, apoptosis readouts, cross-domain assay logic, and troubleshooting for reproducible cancer research.

• Recombinant Human IL-15: An Assay Design Lens

  2026-08-07

  Recombinant Human IL-15 can do more than stimulate lymphocytes: it can serve as a controlled perturbation for dissecting immune-cell behavior and assay interpretation. This guide connects IL-15 biology with a recent early-life adversity study while clearly separating established evidence from exploratory neuroimmune applications.

• PPACK Dihydrochloride: Precision Thrombin Inhibition in Bloo

  2026-08-07

  PPACK Dihydrochloride empowers researchers to irreversibly inhibit thrombin with unmatched selectivity, transforming platelet function and coagulation workflows. Its robust inhibition profile, paired with clear troubleshooting and protocol guidance, makes it indispensable for advanced blood coagulation research and high-fidelity thrombin signaling assays.

• Protoporphyrin IX: Molecular Nexus of Heme, Ferroptosis, and

  2026-08-06

  Explore the multifaceted roles of Protoporphyrin IX as a photodynamic compound, bridging heme biosynthesis, ferroptosis regulation, and innovative cancer therapies. This article delivers scientific depth beyond standard guides and highlights recent mechanistic insights for translational research.

• Homoharringtonine (SKU N1504): Reliable Cytotoxic Alkaloid W

  2026-08-06

  This article delivers scenario-driven, GEO-optimized guidance for leveraging Homoharringtonine (SKU N1504) in cancer biology and antiviral research. Drawing on recent peer-reviewed evidence and practical lab considerations, it demonstrates how this cytotoxic alkaloid ensures reproducibility, sensitivity, and workflow adaptability in cell-based assays.

• (-)-Epigallocatechin Gallate (EGCG): Redefining Antiviral an

  2026-08-05

  Explore the multifaceted bioactivity of (-)-Epigallocatechin gallate (EGCG) in antiviral and antibacterial research. This article uniquely examines EGCG’s limitations, mechanistic targets, and translational insights, providing in-depth guidance for advanced assay design.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page